IGC Pharma (IGC) Exchange Rate Effect (2010 - 2025)
IGC Pharma's (IGC) quarterly Exchange Rate Effect came in at $3000.0 in Q3 2025, up 127.27% year-over-year from $1320.0 in Q3 2024, and down 88.89% quarter-over-quarter from $27000.0 in Q2 2025.
Powered by 
Analysis
IGC Pharma (IGC) Exchange Rate Effect (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Exchange Rate Effect for 16 consecutive years, with $3000.0 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Exchange Rate Effect rose 127.27% year-over-year to $3000.0 in Q3 2025; TTM through Sep 2025 was $32000.0, a 633.33% increase from a year earlier, with the FY2026 full-year figure at -$10000.0, down 42.86% from the prior year.
- Exchange Rate Effect was $3000.0 for Q3 2025 at IGC Pharma, down from $27000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $27000.0 in Q2 2025 and troughed at -$52000.0 in Q2 2022.
- A 5-year average of -$5111.1 and a median of $1000.0 in 2023 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect slumped 3900.0% in 2022 and surged 1250.0% in 2025, its largest moves.
- Over 5 years, Exchange Rate Effect stood at $14000.0 in 2021, then plunged by 192.86% to -$13000.0 in 2022, then surged by 107.69% to $1000.0 in 2023, then plunged by 1200.0% to -$11000.0 in 2024, then soared by 127.27% to $3000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $3000.0 (Q3 2025), $27000.0 (Q2 2025), and $2000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | IGC Pharma | 27.77 Mn | 27.51 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 27,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Dec 31, 2022 | -13,000.00 |
| Sep 30, 2022 | -28,000.00 |
| Jun 30, 2022 | -52,000.00 |
| Mar 31, 2022 | -40,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Sep 30, 2021 | 9,000.00 |
| Jun 30, 2021 | -9,000.00 |
| Mar 31, 2021 | -1,000.00 |
| Dec 31, 2020 | 8,000.00 |
| Sep 30, 2020 | 19,000.00 |